Clebopride malate

CAS No. 57645-91-7

Clebopride malate( —— )

Catalog No. M20810 CAS No. 57645-91-7

Clebopride malate is a dopamine antagonist drug?Used to treat functional gastrointestinal disorders such as nausea or vomiting.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 Get Quote
10MG 60 Get Quote
25MG 95 Get Quote
50MG 132 Get Quote
100MG 222 Get Quote
200MG 331 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Clebopride malate
  • Note
    Research use only, not for human use.
  • Brief Description
    Clebopride malate is a dopamine antagonist drug?Used to treat functional gastrointestinal disorders such as nausea or vomiting.
  • Description
    Clebopride malate is a dopamine antagonist drug?Used to treat functional gastrointestinal disorders such as nausea or vomiting.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine
  • Research Area
    Metabolic Disease
  • Indication
    Gastroesophageal reflux and functional dyspepsia

Chemical Information

  • CAS Number
    57645-91-7
  • Formula Weight
    507.96
  • Molecular Formula
    C24H30ClN3O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:34 mg/mL (66.93 mM)
  • SMILES
    COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1.O=C(O)CC(O)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bleiberg H Piccart M Lips S et al. A phase I trial of a new antiemetic drug--clebopride malate--in cisplatin-treated patients[J]. Annals of Oncology Official Journal of the European Society for Medical Oncology 1992 3(2):141.
molnova catalog
related products
  • (+)-PD 128907 hydroc...

    (+)-PD 128907 hydrochloride is an agonist of D3 dopamine receptor .

  • GSK598809

    GSK598809 (GSK-598809) is a potent, selective, CNS penetrant and orally bioavailable dopamine D3 receptor antagonist with pKi of 8.9; displays >100-fold selectivity over D2 and H1 receptors.

  • SB-277011

    A potent and selective dopamine D3 receptor antagonist with pKi of 8.0.